Amsterdam Cardiovascular Sciences
-
Diagnostic and epidemiological landscape of anaerobic bacteria in Europe, 2020–2023 (ANAEuROBE)
Boattini, M., Bianco, G., Bastos, P., Mavromanolaki, V. E., Maraki, S., Spiliopoulou, A., Kakouris, V., Kalchev, Y., Budimir, A., Bedenić, B., Rubic, Z., Licker, M., Musuroi, C., Juhász, E., Kristóf, K., Pirs, M., Velimirovic, I., Berktold, M., Liptáková, A. & Krajcikova, A. & 64 others, , 1 Jun 2025, In: International journal of antimicrobial agents. 65, 6, 107478.Research output: Contribution to journal › Article* › Academic › peer-review
-
The evidence base for the optimal antibiotic treatment duration of upper and lower respiratory tract infections: an umbrella review
Kuijpers, S. M. E., Buis, D. T. P., Ziesemer, K. A., van Hest, R. M., Schade, R. P., Sigaloff, K. C. E. & Prins, J. M., Jan 2025, In: The Lancet Infectious Diseases. 25, 1, p. 94-113 20 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Rapid extended-spectrum beta-lactamase-confirmation by using a machine learning model directly on routine automated susceptibility testing results
the ISIS-AR study group, 2025, In: Frontiers in microbiology. 16, 1582703.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications